Chemotherapy and Radiation
687 articles
New AI Tool Brings Hope in Quest for Earlier Detection
Can AI help catch pancreatic cancer at an earlier stage? Dr. Michael Rosenthal and others are working on an AI tool to do just that.
Privacy Policy
At Let’s Win, we take your privacy seriously. Please read the following Privacy Policy (the “Privacy Policy”) in order to learn more about our policies, practices, and procedures regarding our website, including the personally identifiable information that we may collect from you, and the uses that we may make of your information. This Privacy Policy […]
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
Pancreatic Cancer Patients Have a Role in Treatment Choices
Pancreatic Cancer UK’s Peter De Rosa explains how patient-reported outcome measures can help direct treatment choices and supportive care.
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
All About End-of-Life Planning: Difficult Conversations
Do you know how to prepare for end-of-life? Do you want to make it easier on your family? Dr. Dawn Gross provides some planning guidelines.
Overcoming Challenges to Vaccine Immunotherapy
Dr. Elizabeth Jaffee explains the challenges facing the scientists developing vaccine-based immunotherapy for pancreatic cancer.
Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.
Exercise Before, During, and After Pancreatic Cancer Treatment Could Save Your Life
Dr. Matthew Katz explains the benefits of even the most modest amount of exercise throughout pancreatic cancer treatment.
Newly Discovered Protein Complex in RAS Pathway May Provide a Treatment Target
Dr. Andrew Aguirre and other researchers from Dana-Farber and the Broad Institute are looking at the RAS pathway for a new target.